InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,259.44
(
0.27%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: caravon post# 4657

Wednesday, 07/30/2008 9:20:59 PM

Wednesday, July 30, 2008 9:20:59 PM

Post# of 4764
Thanks for your opinion. 11F8 is an EGFR-drug, specifically a phage derived human anti-EGFR. Strictly speaking 11F8 is NOT a humanized/CDR-grafted antibody. I'm not sure how this will be treated from a legal standpoint.

The question that I have is the following: does 11F8 have any meaurable efficacy advantage over Erbitux?

We will see what happens in a couple of months.

Regards,

biophud
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up